Illumina, Inc. (BIT:1ILMN)

Market Cap	14.75B -26.5%
Revenue (ttm)	3.69B -0.7%
Net Income	722.50M
EPS	4.63
Shares Out	n/a
PE Ratio	20.41
Forward PE	22.02
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	14
Open	98.92
Previous Close	98.92
Day's Range	98.92 - 98.92
52-Week Range	61.21 - 132.28
Beta	n/a
RSI	24.71
Earnings Date	Feb 5, 2026

About Illumina

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole...

• Industry: Laboratory Analytical Instruments
• Founded: 1998
• Employees: 9,030
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1ILMN

Financial Performance

Financial numbers in USD